Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Pharmaceutical News Stories - November 2008

Date Title Comments Rating
2008-11-30 Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain 0 None
2008-11-26 Watson Pharmaceuticals receives FDA approval for generic Wellbutrin XL 0 None
2008-11-26 Sun Pharma acquires Chattem Chemicals, Inc 0 None
2008-11-26 Generic drug competition benefits Ontarians 0 None
2008-11-26 FDA issues complete response letter for Ceftobiprole for treatment of complicated skin infections 0 None
2008-11-26 MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease 0 None
2008-11-25 Scientists create synthetic Heparin in more varieties 0 None
2008-11-25 Roche to acquire Memory Pharmaceuticals 0 None
2008-11-25 Selzentry (maraviroc) becomes fully approved HIV antiretrovial 0 None
2008-11-25 Caraco Pharmaceutical Labs responds to FDA warning 0 None
2008-11-25 Febuxostat recommended by panel for treatment of hyperuricemia in patients with gout 0 None
2008-11-24 Live oral Shigella vaccine licensed to PATH 0 5
2008-11-24 Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis 0 None
2008-11-24 FDA accepts Labopharm's NDA for formulation of trazodone 0 None
2008-11-24 King Pharmaceuticals and Alpharma sign definitive merger agreement 0 None
2008-11-24 Tapentadol hydrochloride approved for pain relief 0 None
2008-11-24 New plan to tackle off-label prescribing 0 None
2008-11-21 Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder 0 3.2
2008-11-21 Nplate receives positive opinion for marketing authorisation in Europe 0 None
2008-11-21 Eli Lilly completes tender offer for ImClone Systems 0 None
2008-11-21 FDA approves tapentadol immediate-release tablets for pain in adults 0 3
2008-11-21 FDA accepts filing and grants priority review for DX-88 for hereditary angioedema 0 None
2008-11-20 Ortho Biotech submits NDA for Trabectedin in relapsed ovarian cancer 0 None
2008-11-20 FDA approves GSK's Promacta (Eltrombopag) 1 None
2008-11-20 FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome 0 None
2008-11-20 FDA strengthens safety of Sucraid (sacrosidase) oral solution 0 None
2008-11-20 FDA accepts Vanda Pharmaceuticals Iloperidone resubmission 0 None
2008-11-20 EPA seeks public comment on proposal to add hazardous pharmaceutical waste to universal waste rule 0 None
2008-11-19 Viral Genetics completes acquisition of V-Clip Pharmaceuticals 0 None
2008-11-19 Prana Biotechnology's compound could halt Alzheimer's pathology 0 None
2008-11-19 Phosphaplatins kill ovarian, testicular, head and neck cancer cells 0 None
2008-11-19 Breakthrough could revolutionise drug development 0 None
2008-11-19 Garlic drug treats diabetes 0 None
2008-11-19 Systems biology brings hope of speeding up drug development 0 None
2008-11-19 Common ADHD drugs do not cause genetic damage in children 0 None
2008-11-19 Scientists discover new compounds to target muscular dystrophy 0 None
2008-11-18 Cancer drug bevacizumab linked to significantly increased risk of blood clots 0 None
2008-11-18 Medications containing barbiturates or narcotics may make migraine worse 0 None
2008-11-18 Mylan receives FDA approval for Fluoxetine capsules 0 None
2008-11-18 Musculoskeletal Center wins $2.2 million to study biologics safety 0 None
2008-11-18 Gel Technologies raises $9 million 0 None
2008-11-18 Targanta Therapeutics announces posting of briefing documents for review of FDA 0 None
2008-11-18 LegitScript shuts down 500 no-prescription-required online pharmacies 0 1
2008-11-18 How should we assess new antimalarial drugs? 0 None
2008-11-18 Fitch Ratings revises Merck & Co.'s outlook 0 None
2008-11-18 Celprogen introduces in vivo model for human glioblastoma 0 None
2008-11-18 Altus Pharmaceuticals reaffirms plan to submit NDA for Trizytek 0 None
2008-11-17 Simple, inexpensive method for detecting contaminants in heparin 0 None
2008-11-17 Governments urged to take broader perspective when considering whether to fund vaccines 0 None
2008-11-13 Osteoporosis drugs may prevent future bone growth 0 None
2008-11-13 TheraQuest's IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA 0 None
2008-11-13 Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections 0 4
2008-11-12 GlaxoSmithKline to acquire Genelabs Technologies 0 None
2008-11-12 FDA warns public of extortion scam by FDA impersonators 0 None
2008-11-11 Calls for a more flexible approach to vaccine funding 0 None
2008-11-10 Xamiol gel provides relief for scalp psoriasis 2 3.8
2008-11-07 FDA seizes Heparin from Cincinnati manufacturer 0 None
2008-11-07 FDA approves Ranexa for the treatment of chronic angina 0 None
2008-11-06 Fenfluramine shown to have serious long-term effects 0 None
2008-11-06 SALVAT submits complete response to FDA approvable letter for CETRAXAL 0 None
2008-11-06 NCPA statement on Florida study about prescription drug prices 0 None
2008-11-05 Investigational drug, MK-677 shows promise for reducing age-related frailty 0 None
2008-11-05 Medicaid policies vary widely for biologic disease-modifying antirheumatic drugs 0 None
2008-11-05 New drug tricks the body into burning off fat 0 None
2008-11-05 Anti-frailty pill for seniors in the pipeline 0 None
2008-11-04 Mylan receives final approval for generic version of antiepileptic Keppra 0 None
2008-11-04 SurModics acquires drug delivery assets of PR Pharmaceuticals 0 None
2008-11-04 Call to explore broader use of human papillomavirus vaccines 0 None
2008-11-03 Anti-VEGF drugs for retinal diseases could have serious side effects 0 None
2008-11-03 Genentech submits application to FDA for Avastin in the most aggressive form of brain cancer 0 None
2008-11-02 FDA accepts Arana's anti-inflammatory IND 0 None
2008-11-02 Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder 0 None

Total

72 posts
3 comments
33 raters